PHASE II TRIAL OF INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, & ETOPOSIDE (CDE) IN HIV-ASSOCIATED NON-HODGKIN'S LYMPHOMA (NHL): AN EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG) TRIAL (E1494).
- 1 May 1999
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 21 (1) , A39
- https://doi.org/10.1097/00126334-199905010-00140